Emerging Microbes & Infections
Volume 6, 2017 - Issue 1
Related Research Data
Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1
Source:
Springer Science and Business Media LLC
Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA.
Source:
Springer Science and Business Media LLC
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.
Source:
Frontiers Media SA
Identification of Novel Mutations in LprG (rv1411c), rv0521, rv3630, rv0010c, ppsC, and cyp128 Associated with Pyrazinoic Acid/Pyrazinamide Resistance in Mycobacterium tuberculosis.
Source:
American Society for Microbiology
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
Source:
Informa UK Limited
Role of rpsA gene sequencing in diagnosis of pyrazinamide resistance.
Source:
American Society for Microbiology
Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide.
Source:
American Society for Microbiology
Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis
Source:
American Society for Microbiology
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.
Source:
Frontiers Media SA
The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against Mycobacterium tuberculosis In Vivo
Source:
University of Illinois at Chicago
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
Source:
Informa UK Limited
pncA Mutations as a Major Mechanism of Pyrazinamide Resistance in Mycobacterium tuberculosis: Spread of a Monoresistant Strain in Quebec, Canada
Source:
American Society for Microbiology
Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2
Source:
Elsevier Ltd.
Mechanisms of Pyrazinamide Action and Resistance
Source:
American Society for Microbiology
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus
Source:
Springer Science and Business Media LLC
Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis
Source:
American Chemical Society (ACS)
Linking provided by
